MarketPulse

mass spectrometry

2 articles
BenzingaBenzinga··Prnewswire

Roche Expands Mass Spectrometry Diagnostics with FDA's 'Moderate Complexity' Approval

Roche's Ionify® steroid assays receive FDA's moderate complexity designation, expanding access to mass spectrometry-based hormone testing across routine clinical laboratories.
RHHBYFDA approvalmass spectrometry
GlobeNewswire Inc.GlobeNewswire Inc.··Seer, Inc.

Seer Showcases Proteograph Platform at US HUPO 2026 Conference

Seer presents its Proteograph platform at US HUPO 2026, showcasing proteomics research across cardiovascular, neurodegenerative, aging, and oncology applications using minimal sample volumes.
SEERproteomicsProteograph Product Suite